4//SEC Filing
Sundy John 4
Accession 0000899243-20-019864
CIK 0001807901other
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 7:33 PM ET
Size
7.6 KB
Accession
0000899243-20-019864
Insider Transaction Report
Form 4
Sundy John
Chief Medical Officer
Transactions
- Purchase
Common Stock
2020-07-21$18.00/sh+2,000$36,000→ 115,826 total - Award
Stock Option (right to buy)
2020-07-17+145,420→ 145,420 totalExercise: $18.00Exp: 2030-07-16→ Common Stock (145,420 underlying)
Footnotes (2)
- [F1]Represents shares purchased through a directed share program in connection with the initial public offering of Pandion Therapeutics, Inc.'s common stock, which closed on July 21, 2020. These shares of common stock were purchased at the public offering price of $18.00 per share.
- [F2]This option award was granted on July 17, 2020. 1/4 of the shares underlying the award shall vest on May 18, 2021, with the remainder of the shares vesting in equal monthly installments following May 18, 2021 through May 18, 2024, subject to the reporting person's continued service on each applicable vesting date.
Documents
Issuer
Pandion Therapeutics, Inc.
CIK 0001807901
Entity typeother
Related Parties
1- filerCIK 0001817410
Filing Metadata
- Form type
- 4
- Filed
- Jul 20, 8:00 PM ET
- Accepted
- Jul 21, 7:33 PM ET
- Size
- 7.6 KB